Form 15-12G DSG Global Inc.

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549	OMB APPROVAL OMB   Number:                  3235-0167   Expires:                   May 31, 2021   Estimated average burden hours   per response......... 1.50
FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 000-53988

 

DSG GLOBAL, INC.

(Exact name of registrant as specified in its charter)

 

207 – 15272 Croydon Drive, Surrey, British Columbia, V3Z 6T3, Canada

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, Par Value $.001

(Title of each class of securities covered by this Form)

 

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

	Rule 12g-4(a)(1)	☒
	Rule 12g-4(a)(2)	☒
	Rule 12h-3(b)(1)(i)	☐
	Rule 12h-3(b)(1)(ii)	☐
	Rule 15d-6	☐
	Rule 15d-22(b)	☐

 

Approximate number of holders of record as of the certification or notice date:        99        

 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:

August 28, 2025

By:

/s/ Robert Stevens, Receiver

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Grey Wind Capital Partners with Maher Services and F. G. Sullivan to Build a Leading New England Water Well Services Platform
• Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
• SL BIO Ltd. and Horizon Space Acquisition II Announce Closing of Business Combination and Listing on the Nasdaq Global Market